(Q39850877)

15 September 2017

Ciprofloxacin concentrations in bone and muscle after oral dosing (English)

1 reference

15 September 2017

Fong IW

1

1 reference

15 September 2017

Ledbetter WH

2

1 reference

15 September 2017

Vandenbroucke AC

3

1 reference

15 September 2017

Simbul M

4

1 reference

15 September 2017

Rahm V

5

1 reference

15 September 2017

language of work or name

English

0 references

publication date

1 March 1986

1 reference

15 September 2017

4

1 reference

Antimicrobial Agents and Chemotherapy

inferred from page(s)

published in

1 reference

15 September 2017

29

1 reference

15 September 2017

3

1 reference

15 September 2017

405-408

1 reference

Antibacterial activities of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin, and nalidixic acid

15 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180403

Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180403

Selection of multiple antibiotic resistance by quinolones, beta-lactams, and aminoglycosides with special reference to cross-resistance between unrelated drug classes.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180403

Determination of Hemoglobin and Its Derivatives

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180403

Pharmacokinetics of ciprofloxacin after oral and parenteral administration

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180403

In vitro activity of ciprofloxacin, a new carboxyquinoline antimicrobial agent

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180403

Antibiotics in acute osteomyelitis in children.

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180403

Ciprofloxacin as therapy for experimental osteomyelitis caused by Pseudomonas aeruginosa

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180403

Clindamycin treatment of osteomyelitis and septic arthritis in children

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180403

A laboratory assessment of ciprofloxacin and comparable antimicrobial agents

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180403

Pharmacokinetics of ciprofloxacin after oral and intravenous administration in healthy volunteers

20 August 2018

1 reference

12 December 2020

Comparative in vitro activity of five quinoline derivatives and five other antimicrobial agents used in oral therapy

1 reference

12 December 2020

Experimental Osteomyelitis. II. Therapeutic Trials and Measurement of Antibiotic Levels in Bone

1 reference

12 December 2020

Further observations on the value of oral penicillins in chronic staphylococcal osteomyelitis

1 reference

12 December 2020

Dose- and sex-independent disposition of ciprofloxacin

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.29.3.405

1 reference

15 September 2017

1 reference

15 September 2017

1 reference